You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

17 June 2020
The TGA has issued five infringement notices totalling $63,000 to Sydney-based company Chemforce Pty Ltd for alleged unlawful advertising in relation to COVID-19.
15 June 2020
The TGA has issued four infringement notices totalling $50,400 to Cairns based company Hydrogen Technologies Pty Ltd for alleged advertising breaches including reference to COVID-19.
4 June 2020
Due to the unprecedented pressures COVID-19 has placed on the pharmaceutical industry, sponsors of listed medicines and registered over-the-counter (OTC) and complementary medicines (RCM) are eligible to request consent not to comply with TGO 92 labelling requirements for a limited time.
4 June 2020
The Federal Court of Australia has made orders restraining MMS Australia from advertising and supplying goods containing certain potentially dangerous substances, including the main chemical used to make 'Miracle Mineral Solution' (MMS), until a further hearing next week.
3 June 2020
New modelling demonstrates that supply of critical medicines for ventilating patients supports a return to elective surgery.
29 May 2020
The TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia.
28 May 2020
The TGA is reminding advertisers that therapeutic goods advertising must not undermine public health campaigns, as the cold and flu season begins in Australia and COVID-19 restrictions are eased.
22 May 2020
The TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.
21 May 2020
Information to help ensure individuals and organisations clearly understand and minimise the risks of reusing face masks and gowns.
21 May 2020
The TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth, including alleged unlawful advertising of therapeutic goods in relation to COVID-19.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us